Connect with us

Asendin (amoxapine)


Amoxapine (or ASENDIN®) is mainly prescribed to treat major depressive disorder.

Status: ACTIVE

Class: Tricyclic (TCA), Tetracyclic (TeCA)

FDA Approval: 1989

Dosage Forms: 25 mg, 50 mg, 100 mg, 150 mg

Biological Half-life: 8-10 hours

Side Effects: Dizziness, dry mouth, constipation, nausea, anxiety, fatigue, blurred vision, confusion, headache, appetite changes, rash, weakness, tachycardia, nightmares, increased suicide risk

Routes of Administration: Oral

Pregnancy Category: C (US)

  www.medlineplus.gov

Like Us

Advertisement
Advertisement